Pacira BioSciences, Inc. PCRX Change in Other Liabilities
Change in Other Liabilities at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingLiabilities.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s change in other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s change in other liabilities?
- Pacira BioSciences, Inc. (PCRX) reported change in other liabilities of $3.29M in Q1 2026.
- How has Pacira BioSciences, Inc.'s change in other liabilities changed year-over-year?
- Pacira BioSciences, Inc.'s change in other liabilities increased by 203.9% year-over-year, from $1.08M to $3.29M.
- What does change in other liabilities mean?
- Change in miscellaneous liabilities affecting operating cash flow.